Dark

ACRS
Aclaris Therapeutics, Inc.
stock NASDAQ

At Close

Sep 25, 2026 4:00:00 PM EDT

5.16USD-4.089%(-0.22)1,474,100

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 25, 2026 8:25:30 AM EDT

5.35USD-0.558%(-0.03)200

After-hours

Sep 25, 2026 4:36:30 PM EDT

5.06USD-2.008%(-0.10)420

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

761.75M

CEO

Neal Walker

Headquarters

Wayne, Pennsylvania, USA

Industry

Diagnostics & Research

Next Earnings

Nov 5, 2026 (40d)

OMER XLV

ACRS Stats

Avg. Vol. 10 Day

3,177,887

Avg. Vol. 30 Day

2,345,430

Employees

Market Cap

761,754,271

Shares Out.

147,198,893

On/Off Exchange

56%/44%

6 Month Beta

1.52

1 Year Beta

0.62

2 Year Beta

0.86

3 Year Beta

0.94

52 Week Low

1.74

52 Week High

6.60

SMA50

5.77

SMA200

4.41

1 Week

-5.91%

1 Month

-16.40%

3 Month

+3.50%

6 Month

+47.02%

1 Year

+160.05%

2 Year

+338.56%

5 Year

-72.47%

Profile

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.

ACRS Stock Summary

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) stock price today is $5.16, and today's volume is 1,474,100. ACRS is down -4.089% today. The 30 day average volume is 2,345,430. ACRS market cap is 761.75M with 147,198,893 shares outstanding.